Atlas Trials

Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors

Clinical trial NCT07396090 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07396090
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2026-01-20
Primary completion
2026-10-31
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.